Schwabe Kaloba Pelargonium Cough and Cold Relief Tablets, 30 g

Product Information

Individually, cefuroxime also showed benefit over placebo for the following outcomes: clinical improvement at follow-up, improvement at physician follow-up and night cough at follow-up, where other antibiotics did not. This was based on a trial of over 300 people, which contributed much of the weight in meta-analyses. The committee discussed this finding and had some concerns that the study design of the cefuroxime study in particular influenced this result. Cals JW, Butler CC, Hopstaken RM, Hood K, Dinant GJ. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ. 2009;338:b1374. Pelargonium sidoides ( P. sidoides, as a liquid) significantly reduced 'failure to resolve all symptoms' by day 7 (61.0% versus 95.3%; very low quality evidence), 'failure to resolve cough' by day 7 (very low quality evidence) and 'failure to resolve sputum' by day 7 (very low quality evidence) compared with placebo in adults with acute bronchitis. The committee agreed that the evidence for inhaled corticosteroids was mixed. There was some evidence that it reduced cough symptoms in adults with an acute or subacute cough (particularly in non-smokers) but other evidence that it had no effect. No evidence for oral corticosteroids was found.

See the BNF for appropriate use and dosing in specific populations, for example, hepatic impairment, renal impairment, pregnancy and breast-feeding. There is no particular guideline for the approximate intake of pelargonium sidoides supplements. However, the safe dosage may vary according to the severity of the disease. In addition, factors like general health, weight, sex, age and ongoing medication can influence it. This product is a traditional herbal medicinal product containing Pelargonium sidoides DC root dried extract. 100g (=93.985 ml) syrup contain 0.2506g dried liquid extract from the roots of Pelargonium sidoides DC (EPs ® 7630).

If you have any questions, or are unsure about anything, please ask your doctor, pharmacist or healthcare practitioner. Possible side-effects Coughing is a leading symptom of viral ARTIs such as AB and CC which may have an annoying and grueling effect on children and adults alike, causing interference with essential activities of daily living and disruption of sleep in patients and their nuclear families [ 5, 16, 17]. In ARTIs, cough may persist for several weeks, causing persistent distress and reduced well-being [ 16, 52]. It is therefore a clinically important treatment target. Experience in Germany suggests that Pelargonium sidoides extracts are safe, with 1 in 189,000 patients experiencing a side effect during an average treatment period of 10 days. A few reports of potential liver problems were found to relate to other causes. Cefuroxime is a broad-spectrum antibiotic (a second generation cephalosporin). The committee discussed that, if an antibiotic is needed to treat an infection that is not life-threatening, a narrow-spectrum antibiotic should generally be first choice. Indiscriminate use of broad-spectrum antibiotics creates a selective advantage for bacteria resistant even to these 'last-line' broad-spectrum agents, and also kills normal commensal flora leaving people susceptible to antibiotic-resistant harmful bacteria such as Clostridium difficile.

Liver problems including hepatitis have been reported when taking this product. However, a causal relationship has not been established. The frequency is not known. After taking this productTell your doctor or pharmacist if any of the above side-effects becomes serious or if you notice any other side-effects not listed above. Reporting of side effects Antibiotics are not normally prescribed for coughs. A GP will only prescribe them if you need them – for example, if you have a bacterial infection or you're at risk of complications. What causes coughs The committee discussed the evidence that inhaled corticosteroids reduced additional treatments being sought, and they could reduce the prescribing of antibiotics for acute cough. However, any prescribed alternatives to antibiotics have workload implications as people are likely to re‑consult and expect similar treatments in the future, sending the wrong message that prescribed treatment is needed for a largely self‑limiting condition.